Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057
The findings indicate that B/F/TAF is both safe and effective for elderly PWH patients with a prolonged and documented history of HIV infection, multiple co-morbidities and concomitant medication.
Authors
- Véronique Joly (ORCID: https://orcid.org/0000-0002-2005-102X)
- Clotilde Allavena (ORCID: https://orcid.org/0000-0003-1010-1270)
- Valentina Isernia (ORCID: https://orcid.org/0000-0002-0981-5041)
- Bao Phung (ORCID: https://orcid.org/0009-0007-2035-063X)
- Diane Descamps (ORCID: https://orcid.org/0000-0002-6556-1525)
- Charlotte Charpentier (ORCID: https://orcid.org/0000-0002-6441-7054)
- Gilles Peytavin (ORCID: https://orcid.org/0000-0002-4359-537X)
- Minh Lê (ORCID: https://orcid.org/0000-0002-4670-8288)
- Lambert Assoumou (ORCID: https://orcid.org/0000-0002-5547-1796)
- Faïza Ajana
- Roland Landman
- Aı̈da Benalychérif
- D. Neau
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Hotel Dieu Hospital (CA)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Pellegrin (FR)
- Centre Hospitalier de Tourcoing (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Hôpital Bichat-Claude-Bernard (FR)
Publication Details
- Journal
- Journal of Infection and Public Health
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.jiph.2025.102946
- Citations
- 1
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.25